Entresto الاتحاد الأوروبي - السلوفاكية - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - zástava srdca - angiotensin ii protivníci, ďalšie kombinácie, agentov konajúcich na renin-angiotensin system - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Neparvis الاتحاد الأوروبي - السلوفاكية - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - zástava srdca - Činidlá pôsobiace na systém renín-angiotenzín - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

ARCOXIA 60 mg سلوفاكيا - السلوفاكية - ŠÚKL (Štátny ústav pre kontrolu liečiv)

arcoxia 60 mg

n.v. organon, holandsko - etorikoxib - 29 - antirheumatica, antiphlogistica, antiuratica

ARCOXIA 90 mg سلوفاكيا - السلوفاكية - ŠÚKL (Štátny ústav pre kontrolu liečiv)

arcoxia 90 mg

n.v. organon, holandsko - etorikoxib - 29 - antirheumatica, antiphlogistica, antiuratica

ARCOXIA 120 mg سلوفاكيا - السلوفاكية - ŠÚKL (Štátny ústav pre kontrolu liečiv)

arcoxia 120 mg

n.v. organon, holandsko - etorikoxib - 29 - antirheumatica, antiphlogistica, antiuratica